Evidence map›Paper›PMID 39738452›Full record

Trial reportScientific reports2024

Promotora intervention for metabolic and mental health to reduce type 2 diabetes risk: a pilot randomized controlled trial.

Maria C Vargas, Joshua B Katz, Azucena Lopez, Arturo Carrillo, Dyanna L Gregory, Matthew J O'Brien

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria C VargasInstitute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA.
Joshua B KatzDivision of Endocrinology, Diabetes, and Metabolism, University of Illinois College of Medicine at Chicago, Chicago, USA.
Azucena LopezInstitute for Policy Research, Northwestern University, Evanston, USA.
Arturo CarrilloBrighton Park Neighborhood Council, Chicago, USA.
Dyanna L GregoryDivision of Digestive & Liver Diseases, Metabolism and Molecular Medicine, The University of Texas Southwestern Medical Center, Dallas, USA.
Matthew J O'BrienInstitute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA. matthew.obrien1@northwestern.edu.

Funding

Promotora Intervention for Metabolic and MentalHealth (PRIME2)R03DK109243 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI O'BRIEN, MATTHEW JAMES · 2017 to 2018
$163k
NIDDK NIH HHS R03 DK109243NIDDK NIH HHS R03-DK109243
6 · The paper itself

Abstract

The objective of this study was to develop and evaluate a novel behavioral intervention (PRIME2) that integrates evidence-based approaches for reducing diabetes risk and perceived stress. We conducted a pilot randomized controlled trial of the 16-session PRIME2 intervention vs. usual care among 40 Spanish-speaking Latinx adults with prediabetes and body mass index (BMI) ≥ 25 kg/m

Indexed as

Diabetes Mellitus, Type 2Mental HealthAdultBody Mass IndexDepressionFemaleGlycated HemoglobinHispanic or LatinoHumansMaleMiddle AgedPilot ProjectsPrediabetic StateRisk FactorsStress, PsychologicalUnited StatesGlycated Hemoglobinhemoglobin A1c protein, humanCommunity health workersDiabetes preventionHispanic healthPromotorasPsychological stress

Identifiers

PMID39738452
PMCPMC11686005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.